国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01099 国药控股

交易中 09-10 13:51:49

15.410

-0.290

-1.85%

最高15.640	最低15.380	成交量218.68万
今开15.560	昨收15.700	日振幅1.66%
总市值480.95亿	流通市值206.77亿	总股本31.21亿
成交额3,377万	换手率0.16%	流通股本13.42亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01099","market":"HK","secType":"STK","nameCN":"国药控股","latestPrice":15.41,"timestamp":1789019507594,"preClose":15.7,"halted":0,"volume":2186817,"delay":0,"changeRate":-0.01847133757961778,"floatShares":1341810740,"shares":3121000000,"eps":2.67741580346431,"marketStatus":"交易中","change":-0.29,"latestTime":"09-10 13:51:49","open":15.56,"high":15.64,"low":15.38,"amount":33772957,"amplitude":0.016561,"askPrice":15.42,"askSize":47200,"bidPrice":15.41,"bidSize":19600,"shortable":3,"etf":0,"ttmEps":2.6523357832022523,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1789027800000},"marketStatusCode":2,"adr":0,"listingDate":1253635200000,"exchange":"SEHK","adjPreClose":15.7,"dividendRate":0.051259,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":0.605702,"lotSize":400,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SNP.HK","impliedVol":0.2351,"impliedVolPercentile":0.2163},"requestUrl":"/m/hq/s/01099","defaultTab":"news","newsList":[{"id":"2665334495","title":"国药控股（01099）宣布与翰森制药（03692）开启全周期战略协同合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2665334495","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665334495?lang=zh_cn&edition=full","pubTime":"2026-09-08 12:34","pubTimestamp":1788842076,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国药控股（01099）9月8日宣布，近日，公司已与翰森制药（03692）达成战略合作。基于双方多年深度合作积淀，围绕深化工商协同、赋能产业高质量发展目标，双方签署战略合作协议，同步落地广阔市场、医疗准入、零售、DTP专项合作协议，推动工商合作由传统业务对接，全面升级为全链条、全周期战略协同。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/MGM1MTEwODE5MDc1ODM4MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGM1MTEwODE5MDc1ODM4MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991005","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1197","BK1191","01099","LU1115378108.SGD","LU0640798160.USD","BK1515","BK1500","BK1589","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665313965","title":"贝莱德在国药控股的H股好仓比例下降0.15%至8.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665313965","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665313965?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:20","pubTimestamp":1788772800,"startTime":"0","endTime":"0","summary":"南财智讯9月7日电，香港交易所披露信息显示，BlackRock,Inc.（贝莱德）在国药控股的H股好仓（L）比例于9月2日从9.07%下降至8.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609073866754446.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609073866754446.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1197","BK1515","01099","LU0640798160.USD","LU1115378108.SGD","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665398249","title":"【券商聚焦】中信建投：上半年收入与利润双增，医药行业步入新发展周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2665398249","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665398249?lang=zh_cn&edition=full","pubTime":"2026-09-07 09:04","pubTimestamp":1788743053,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，2026年上半年医药行业整体收入与扣非净利润实现双增长，创新药、CXO、制药装备及科学试剂等板块积极复苏，行业步入新发展周期。创新药收入+58.68%，扭亏为盈，出海总金额超900亿美元，全年有望超越2025年水平，国际化持续兑现；CXO收入+25.2%，扣非净利润+66.5%，订单旺盛，上行周期确立。随着集采出清、创新放量、出海落地及上游国产化提升，行业有望开启高质量发展周期，龙头将持续受益。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990791","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","LU1720050803.USD","LU0348827113.USD","LU1969619763.USD","601066","BK1585","BK1588","IE00B3M56506.USD","BK1593","BK1197","KCE","BK1583","BK1574","02367","BK1161","KURE","06160","LU1115378108.SGD","LU2476274308.USD","LU2476274720.SGD","HK0000165453.HKD","03933","BK1141","06821","IE00BPRC5H50.USD","01530","SG9999004311.SGD","09688","BK1515","IE00B5MMRT66.SGD","LU0228659784.USD","BK1207","LU2399975544.HKD","02196","02268","09926","BK1500","LU0348825331.USD","01099","LU0588546209.SGD","LU0828237510.HKD","02228","LU0417516902.SGD","LU2488822045.USD","LU2778985437.USD","01789","LU0640798160.USD","BK1100","LU2328871848.SGD","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131274850","title":"国药控股8月股份变动月报显示股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1131274850","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131274850?lang=zh_cn&edition=full","pubTime":"2026-09-04 16:53","pubTimestamp":1788512032,"startTime":"0","endTime":"0","summary":"国药控股股份有限公司于2026年9月4日公布截至2026年8月31日的股份变动月报。报告期内，各类已发行股份及注册股本均未发生增减变动。报告期内，未出现新增发行、股份购回、注销及库藏股变化，股权激励及期权事项亦无变动。公司表示，截至本月末，其H股维持充足的公眾持股比例，符合香港联合交易所有限公司《上市规则》等法律法规要求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878268","title":"贝莱德在国药控股的H股好仓比例下降0.18%至8.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878268","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664878268?lang=zh_cn&edition=full","pubTime":"2026-09-03 17:24","pubTimestamp":1788427440,"startTime":"0","endTime":"0","summary":"南财智讯9月3日电，香港交易所披露信息显示，BlackRock,Inc.（贝莱德）在国药控股的H股好仓（L）比例于8月31日从9.11%下降至8.93%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609033864136039.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609033864136039.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1197","LU0640798160.USD","BK1500","LU1115378108.SGD","01099","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119060311","title":"国药控股（01099）将于9月15日召开股东特别大会，审议15名董事连任","url":"https://stock-news.laohu8.com/highlight/detail?id=1119060311","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119060311?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:22","pubTimestamp":1788168152,"startTime":"0","endTime":"0","summary":"国药控股8月31日发布通告，宣布公司将于2026年9月15日（星期二）上午9时在上海市黄浦区龙华东路385号国药控股大厦1401会议室召开股东特别大会。会议拟审议以下普通决议案：。公司H股股东名册将于9月10日至9月15日暂停过户。欲在大会上行使表决权的H股股东，须于9月9日16:30前将过户文件递交至香港中央证券登记有限公司。股东可委任代理人出席并投票，会议预计不超过半天，相关交通及住宿费用由股东自理。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180532970","title":"国药控股（01099）拟重选全部董事并于9月15日召开股东特别大会","url":"https://stock-news.laohu8.com/highlight/detail?id=1180532970","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180532970?lang=zh_cn&edition=full","pubTime":"2026-08-31 16:41","pubTimestamp":1788165663,"startTime":"0","endTime":"0","summary":"2026年8月31日，国药控股股份有限公司发布通函，披露第七届董事会成员重选安排，并宣布将于2026年9月15日（星期二）上午9时正在中国上海市黄浦区龙华东路385号国药控股大厦1401会议室召开股东特别大会。通函显示，公司第六届董事会任期将于2026年9月14日届满，董事会已于2026年8月21日通过决议，提请股东大会审议全部董事的重选事项。根据公司章程，上述候选人须经股东特别大会批准后方可就任。公司表示，将与获选董事分别签署服务合约。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662066765","title":"国药控股(01099)：国药一致中期归母净利润6.06亿元 同比减少8.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662066765","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662066765?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:56","pubTimestamp":1787911018,"startTime":"0","endTime":"0","summary":"智通财经APP讯，国药控股(01099)发布国药一致截至2026年6月30日止六个月业绩，营业总收入362.66亿元人民币，同比减少1.44%;归属于上市公司股东的净利润6.06亿元，同比减少8.97%;基本每股收益0.99元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488058.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000028","01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150689680","title":"国药控股（01099）披露子公司一致药业2026年中期报告：营收362.66亿元，同比降1.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=1150689680","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150689680?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:53","pubTimestamp":1787910812,"startTime":"0","endTime":"0","summary":"2026年8月28日，国药控股发布海外监管公告，披露其A、B股子公司——国药集团一致药业股份有限公司2026年半年度业绩。报告期内，公司主要财务数据如下：。报告期内研发费用投入3482.13万元，同比减少70.06%。截至报告期末，公司继续强化分销与零售双轮驱动，保持市场份额的同时，面对行业价格压力与政策变动，采取精益管理与结构调整措施。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162658735","title":"国药控股 (01099.HK)：子公司国药一致 2026 年上半年营收 362.66 亿元，同比微降 1.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=1162658735","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162658735?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:46","pubTimestamp":1787910393,"startTime":"0","endTime":"0","summary":"国药控股股份有限公司8 月 28 日公告披露，其附属公司国药集团一致药业股份有限公司截至 2026 年 6 月 30 日止六个月的主要未经审计财务数据。报告期内，国药一致实现营业总收入 362.66 亿元，较上年同期的 367.97 亿元下降 1.44%。资产规模方面，截至 2026 年 6 月 30 日，国药一致总资产为 481.71 亿元，较期初的 490.96 亿元减少 1.89%；归属于上市公司股东的净资产为 188.73 亿元，较期初的 186.10 亿元增长 1.42%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662795539","title":"高盛：降国药控股(01099.HK)目标价至18.46港元 第二季业绩符预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2662795539","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662795539?lang=zh_cn&edition=full","pubTime":"2026-08-26 15:44","pubTimestamp":1787730269,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0640798160.USD","BK1197","LU1115378108.SGD","BK1500","01099","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662798724","title":"大行评级丨高盛：下调国药控股目标价至18.46港元，毛利率压力略大于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2662798724","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662798724?lang=zh_cn&edition=full","pubTime":"2026-08-26 15:08","pubTimestamp":1787728129,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1197","LU0640798160.USD","01099","BK1515","LU1115378108.SGD","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662097761","title":"国药控股与阿斯利康启动基药惠民专项合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2662097761","media":"南方财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662097761?lang=zh_cn&edition=full","pubTime":"2026-08-26 11:23","pubTimestamp":1787714595,"startTime":"0","endTime":"0","summary":"南方财经8月26日电，据国药控股消息，近日，国药控股与阿斯利康在上海召开高层战略合作交流会，并正式启动基药惠民专项合作。阿斯利康作为国药控股核心战略合作伙伴，双方在医药流通、创新服务、民生惠民等多个核心领域已形成深度协作。此次项目启动，标志着聚焦国家基药政策落地与基层医疗可及性提升，双方合作已向更深层次、更广领域迈进。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608263854365220.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608263854365220.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["AZN","01099","LU0708994859.HKD","LU0640798160.USD","LU2237443382.USD","BK1500","LU0029864427.USD","LU0310800379.SGD","LU2237443895.HKD","LU0320765992.SGD","LU0058720904.USD","LU2089984988.USD","LU1267930573.SGD","BK4007","BK4585","LU2237443465.HKD","LU1115378108.SGD","LU2468319806.SGD","LU1829250122.USD","LU2417539215.USD","BK4588","LU2456880835.USD","BK1515","LU0889565916.HKD","LU0289739699.SGD","BK1197","LU2462157665.USD","LU0432979614.USD","AZNH","LU2237443978.SGD","LU2237443549.SGD","BK4568","LU0128525929.USD","LU2236285917.USD","LU2237443622.USD","LU0109394709.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662678804","title":"大行评级丨大和：国药控股上半年业绩略逊预，目标价降至17港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662678804","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662678804?lang=zh_cn&edition=full","pubTime":"2026-08-25 11:27","pubTimestamp":1787628422,"startTime":"0","endTime":"0","summary":"大和发表报告指，国药控股上半年业绩略逊预。总收入同比下跌1.1%至2828亿元，净利润同比下跌1.8%至34亿元。期间，零售收入持续保持良好成长势头，其中药品分销收入下降，而医疗器材分销收入则基本保持稳定。大和认为，维持稳定的传统分销业务并拓展创新服务，是国药推动未来收入增长的关键。该行维持对其“持有”评级，目标价由18港元降至17港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260825/32345964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["EWH","01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662420043","title":"大和：降国药控股(01099.HK)目标价至17港元 上半年业绩略逊预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2662420043","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662420043?lang=zh_cn&edition=full","pubTime":"2026-08-25 10:18","pubTimestamp":1787624320,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1197","LU0640798160.USD","BK1515","BK1500","LU1115378108.SGD","01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144631821","title":"国药控股（01099）发布2026年上半年债务融资工具存续期报告：存续规模合计60亿元 评级展望保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1144631821","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144631821?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:57","pubTimestamp":1787569031,"startTime":"0","endTime":"0","summary":"国药控股股份有限公司8月24日于香港交易所公告，按《香港联合交易所有限公司证券上市规则》第13.10B条要求披露《2026年半年度债务融资工具存续期报告》，涉及两只在银行间及交易所市场流通的债务融资工具，存续余额合计60亿元，信用评级及展望均保持不变。报告期内，上述债务融资工具及发行人主体评级未发生调整。国药控股表示，将继续严格遵循相关法规，及时、准确履行信息披露义务。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187487373","title":"国药控股(01099)发布2026年中期债券报告：上半年营收2828亿元 归母净利34亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1187487373","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187487373?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:55","pubTimestamp":1787568937,"startTime":"0","endTime":"0","summary":"2026年8月24日，国药控股股份有限公司披露2026年公司债券中期报告，公布上半年主要经营及财务数据。医药分销收入2,489.99亿元，占比88.05%，毛利率5.97%。医药零售收入283.60亿元，占比10.03%，毛利率10.37%。本期财务报告未经审计。公司承诺持续及时、准确履行信息披露义务。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661093249","title":"国药控股(01099.HK)发布中期业绩 归母净利润34.04亿元 同比减少1.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661093249","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661093249?lang=zh_cn&edition=full","pubTime":"2026-08-24 07:50","pubTimestamp":1787529012,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01099","BK1515","BK1197","LU0640798160.USD","BK1500","LU1115378108.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661249200","title":"国药控股(01099.HK)：上半年归母净利润34.04亿元 同比下降1.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661249200","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661249200?lang=zh_cn&edition=full","pubTime":"2026-08-24 07:37","pubTimestamp":1787528221,"startTime":"0","endTime":"0","summary":"格隆汇8月24日丨国药控股公布中期业绩，2026年上半年，集团在董事会及管理层的带领下，深刻洞察行业形势，锚定高质量发展的战略目标，聚焦医药流通核心主业，着力于经营质量提升、风险管控和数字化转型的重点任务，上半年业务稳健运营，提质增效成果显现。截至报告期末，集团实现营业收入人民币2828亿元，较去年同期微降1.13%；净利润为人民币51.80亿元，同比下降2.95%；归母净利润为人民币34.04亿元，同比下降1.79%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260824/32344061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661424964","title":"国药控股：上半年营收2,828亿元人民币，上半年营业利润71.5亿元人民币，上半年净利润34.0亿元人民币。上半年毛利率","url":"https://stock-news.laohu8.com/highlight/detail?id=2661424964","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661424964?lang=zh_cn&edition=full","pubTime":"2026-08-24 07:13","pubTimestamp":1787526813,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0640798160.USD","LU1115378108.SGD","BK1515","BK1500","BK1197","01099"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinopharmgroup.com.cn","stockEarnings":[{"period":"1week","weight":0.0235},{"period":"1month","weight":-0.0797},{"period":"3month","weight":-0.0179},{"period":"6month","weight":-0.2195},{"period":"1year","weight":-0.111},{"period":"ytd","weight":-0.1513}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":-0.0255},{"period":"3month","weight":0.0423},{"period":"6month","weight":-0.0075},{"period":"1year","weight":-0.0256},{"period":"ytd","weight":-0.0139}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"国药控股股份有限公司是一家主要从事药品、医疗保健产品及医疗器械批发和零售业务的中国公司。该公司通过四个部门运营业务。医药分销部门为国内外药品及保健品制造商及其他供货商提供分销、物流及其他加值服务。器械分销部门向客户分销医疗器材。医药零售业务部门拥有直接经营或特许经营的零售药局网路。其他业务部门从事药品、化学试剂及实验室用品的制造与销售。","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.004652},{"month":2,"riseRate":0.588235,"avgChangeRate":0.029404},{"month":3,"riseRate":0.470588,"avgChangeRate":0.00701},{"month":4,"riseRate":0.411765,"avgChangeRate":0.016475},{"month":5,"riseRate":0.588235,"avgChangeRate":-0.009205},{"month":6,"riseRate":0.411765,"avgChangeRate":-0.006214},{"month":7,"riseRate":0.529412,"avgChangeRate":-0.008781},{"month":8,"riseRate":0.411765,"avgChangeRate":0.005041},{"month":9,"riseRate":0.470588,"avgChangeRate":-0.009763},{"month":10,"riseRate":0.647059,"avgChangeRate":0.042281},{"month":11,"riseRate":0.470588,"avgChangeRate":-0.00729},{"month":12,"riseRate":0.529412,"avgChangeRate":-0.004119}],"exchange":"SEHK","name":"国药控股","nameEN":"SINOPHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药控股(01099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药控股,01099,国药控股股票,国药控股股票老虎,国药控股股票老虎国际,国药控股行情,国药控股股票行情,国药控股股价,国药控股股市,国药控股股票价格,国药控股股票交易,国药控股股票购买,国药控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药控股(01099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}